Medicamen Biotech Limited Total Liabilities
Medicamen Biotech Limited total liabilities. Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has total liabilities worth Rs-2.76 Billion INR (≈ $-29.80 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Medicamen Biotech Limited (MEDICAMEQ) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Medicamen Biotech Limited (2006–2026)
Total liabilities of Medicamen Biotech Limited from 2006 to 2026. This chart illustrates how Medicamen Biotech Limited's total liabilities have evolved over time, based on quarterly financial data.
Medicamen Biotech Limited Competitors by Total Liabilities
The table below lists competitors of Medicamen Biotech Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Softcat plc
LSE:SCT
|
UK | GBX919.96 Million |
|
SGA Solutions Co.Ltd
KQ:184230
|
Korea | ₩94.61 Billion |
|
Rosebank Industries PLC
LSE:ROSE
|
UK | GBX1.09 Billion |
|
Mobilicom Limited American Depositary Shares
NASDAQ:MOB
|
USA | $7.15 Million |
|
Konfrut Gida Sanayi ve Ticaret AS
IS:KNFRT
|
Turkey | TL2.13 Billion |
|
HLV LIMITED
NSE:HLVLTD
|
India | Rs1.71 Billion |
|
Uniform Industrial Corp
TW:2482
|
Taiwan | NT$270.12 Million |
|
UPA Corporation Bhd
KLSE:7757
|
Malaysia | RM29.74 Million |
Liability Composition Analysis (2006–2026)
This chart breaks down Medicamen Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Medicamen Biotech Limited's balance sheet.
Liquidity & Leverage Metrics
Medicamen Biotech Limited Total Liabilities Ratios Explained
Medicamen Biotech Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medicamen Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medicamen Biotech Limited (2006–2026)
The table below shows the annual total liabilities of Medicamen Biotech Limited from 2006 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs964.38 Million ≈ $10.43 Million |
+14.67% |
| 2025-03-31 | Rs841.04 Million ≈ $9.10 Million |
-3.95% |
| 2024-03-31 | Rs875.67 Million ≈ $9.47 Million |
+2.89% |
| 2023-03-31 | Rs851.03 Million ≈ $9.20 Million |
+7.42% |
| 2022-03-31 | Rs792.24 Million ≈ $8.57 Million |
+29.63% |
| 2021-03-31 | Rs611.18 Million ≈ $6.61 Million |
+1.75% |
| 2020-03-31 | Rs600.66 Million ≈ $6.50 Million |
+20.23% |
| 2019-03-31 | Rs499.59 Million ≈ $5.40 Million |
+16.34% |
| 2018-03-31 | Rs429.43 Million ≈ $4.64 Million |
-7.89% |
| 2017-03-31 | Rs466.20 Million ≈ $5.04 Million |
+10.71% |
| 2016-03-31 | Rs421.09 Million ≈ $4.55 Million |
-18.20% |
| 2015-03-31 | Rs514.78 Million ≈ $5.57 Million |
+7.15% |
| 2014-03-31 | Rs480.41 Million ≈ $5.20 Million |
-2.98% |
| 2013-03-31 | Rs495.17 Million ≈ $5.36 Million |
+1.46% |
| 2012-03-31 | Rs488.06 Million ≈ $5.28 Million |
-1.61% |
| 2011-03-31 | Rs496.06 Million ≈ $5.36 Million |
+19.76% |
| 2010-03-31 | Rs414.22 Million ≈ $4.48 Million |
+26.09% |
| 2009-03-31 | Rs328.50 Million ≈ $3.55 Million |
-18.26% |
| 2008-03-31 | Rs401.88 Million ≈ $4.35 Million |
+10.58% |
| 2007-03-31 | Rs363.44 Million ≈ $3.93 Million |
+43.93% |
| 2006-03-31 | Rs252.51 Million ≈ $2.73 Million |
-- |
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, and sells pharmaceutical formulations in India and internationally. The company provides tablets, capsules, dry syrups, oral liquids, ointments, and other pharmaceutical dosage forms. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-m… Read more